The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium has been established as a large research network for investigating STereotactic Arrhythmia Radioablation (STAR) for ventricular tachycardia (VT). The aim is to provide a pooled treatment database to evaluate patterns of practice and outcomes of STAR and finally to harmonize STAR within Europe. The consortium comprises 31 clinical and research institutions. The project is divided into nine work packages (WPs): (i) observational cohort; (ii) standardization and harmonization of target delineation; (iii) harmonized prospective cohort; (iv) quality assurance (QA); (v) a...
Ventricular tachycardia (VT) is a potentially lethal complication of structural heart disease. Despi...
Failure of drugs and catheter ablation procedures for the treatment of ventricular arrhythmias is st...
BackgroundStereotactic arrhythmia radioablation (STAR) is a potential new therapy for patients with ...
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Th...
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Th...
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main fund...
Stereotactic ablative radiotherapy (SABR) is highly focused radiation therapy that targets well-dema...
Catheter ablation (CA) is a fundamental therapeutic option for the treatment of recurrent ventricula...
Abstract: The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR (stereo...
Patients with ventricular tachycardia are usually treated with antiarrhythmic drugs and ablation if ...
BACKGROUND AND PURPOSE Several studies have suggested stereotactic arrhythmia radioablation (STAR...
AIM: To identify the optimal STereotactic Arrhythmia Radioablation (STAR) strategy for individual pa...
Ventricular tachycardia (VT) occurs most commonly in the presence of structural heart disease or myo...
Linac-based STereotactic Arrhythmia Radioablation (STAR) is a safety and effective approach for sele...
Cardiology and Radiation Oncology working together—a new ‘STAR’ on the horizon? Until recently, mos...
Ventricular tachycardia (VT) is a potentially lethal complication of structural heart disease. Despi...
Failure of drugs and catheter ablation procedures for the treatment of ventricular arrhythmias is st...
BackgroundStereotactic arrhythmia radioablation (STAR) is a potential new therapy for patients with ...
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Th...
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Th...
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main fund...
Stereotactic ablative radiotherapy (SABR) is highly focused radiation therapy that targets well-dema...
Catheter ablation (CA) is a fundamental therapeutic option for the treatment of recurrent ventricula...
Abstract: The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR (stereo...
Patients with ventricular tachycardia are usually treated with antiarrhythmic drugs and ablation if ...
BACKGROUND AND PURPOSE Several studies have suggested stereotactic arrhythmia radioablation (STAR...
AIM: To identify the optimal STereotactic Arrhythmia Radioablation (STAR) strategy for individual pa...
Ventricular tachycardia (VT) occurs most commonly in the presence of structural heart disease or myo...
Linac-based STereotactic Arrhythmia Radioablation (STAR) is a safety and effective approach for sele...
Cardiology and Radiation Oncology working together—a new ‘STAR’ on the horizon? Until recently, mos...
Ventricular tachycardia (VT) is a potentially lethal complication of structural heart disease. Despi...
Failure of drugs and catheter ablation procedures for the treatment of ventricular arrhythmias is st...
BackgroundStereotactic arrhythmia radioablation (STAR) is a potential new therapy for patients with ...